Mick Edmonds, PhD, presented a talk titled “Identifying ncRNA necessary for lung cancer progression” for the HudsonAlpha Research Seminar on November 1 in the HudsonAlpha auditorium.
Edmonds obtained both his BS and MS in molecular biology from Washington State University in Pullman and PhD in molecular and cellular pathology from the University of Alabama at Birmingham (UAB). In 2016, he joined the faculty in the Genetics Department at UAB. Edmonds’ thesis work focused on elucidating the complex transcriptional and epigenetic events required for breast cancer metastasis. He received many awards and a Department of Defense pre-doctoral fellowship during his thesis studies. As a postdoc, his research and training focused on identifying novel initiators and drivers of human lung cancer, using patient lung tumors and genetically engineered mouse models. While training at Vanderbilt, he was awarded a National Research Service Award and an American Cancer Society and Kirby Foundation Postdoctoral fellowship. He also identified a novel driver of human lung cancer, miR-31, which was the first miRNA shown to drive epithelial cancer progression. His lab at UAB is currently examining the role of novel miRNA involved in breast cancer metastasis and identifying ncRNA necessary for lung cancer progression.
Greg Barsh, MD, PhD, hosted the Wednesday seminar. The next HudsonAlpha Research Seminar will be Wednesday, November 15, featuring Nancy Cox, PhD, of the Vanderbilt University School of Medicine.
More information on HudsonAlpha Research Seminars can be found at hudsonalpha.org/seminars.
